| The neutrophil-lymphocyte ratio and its relationship with insulin resistance in obesity S Karakaya, M Altay, FK Efe, İ Karadağ, O Ünsal, O Bulur, M Eser, ... Turkish Journal of Medical Sciences 49 (1), 245-248, 2019 | 44 | 2019 |
| Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy C Karacin, T Eren, E Zeynelgil, GI Imamoglu, M Altinbas, I Karadag, ... Future Oncology 17 (33), 4447-4456, 2021 | 39 | 2021 |
| Association of neutrophil-to-lymphocyte ratio and microalbuminuria in patients with normal eGFR AA Kutlugun, FA Ebinc, MT Ozturk, FK Efe, İ Karadag, M Eser, O Unsal, ... Romanian Journal of Internal Medicine 56 (1), 21-26, 2018 | 15 | 2018 |
| Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy C Karacin, B Oksuzoglu, A Demirci, M Keskinkılıç, NK Baytemür, F Yılmaz, ... BMC cancer 23 (1), 136, 2023 | 11 | 2023 |
| CROSS or FLOT in distal esophageal and gastroesophageal cancer I Karadag, S Karakaya, O Ates, OBC Oksuzoglu J Coll Physicians Surg Pak 31 (3), 326-9, 2021 | 9 | 2021 |
| The role of insulin-like growth factor-1 on steatohepatitis. K Dal, O Bulur, N Ata, AO Yeniova, S Baser, S Karakaya, O Unsal, ... Acta Gastro-Enterologica Belgica 80 (1), 21-24, 2017 | 8 | 2017 |
| The potential prognostic novel markers PIV and PILE score to predict survival outcomes at hepatocellular cancer. I Karadağ, S Karakaya, ME Yilmaz, ÖBÇ Öksüzoğlu European Review for Medical & Pharmacological Sciences 26 (20), 2022 | 7 | 2022 |
| Can neutrophil-to-lymphocyte ratio or platelet-to lymphocyte ratio predict chemotherapy response in testicular cancer S Karakaya, I Karadag, O Ates, OBC Oksuzoglu Eurasian J Med Investig 5, 269-73, 2021 | 6 | 2021 |
| Does Use of Anethum Graveolens Affected Thyroid Hormone Levels and Thyroid Nodules? M Altay, I Ates, FK Efe, I Karadag American Journal of Therapeutics 24 (5), e627-e629, 2017 | 5 | 2017 |
| High neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and low lymphocyte levels are correlated with worse pathological complete response rates S Karakaya, İ Karadağ, ME Yılmaz, ÖBÇ Öksüzoğlu Cureus 14 (3), 2022 | 4 | 2022 |
| Clinical outcomes and prognostic factors in HER-2 positive breast cancer with brain metastasis: a single-centre experience S Karakaya, I Karadag, O Ates, OB Cakmak Oksuzoglu, U Demirci J Coll Physicians Surg Pak 31 (2), 166-170, 2021 | 4 | 2021 |
| Evaluation of factors predicting pathologic complete response in locally advanced HER2 positive breast cancer treated with neoadjuvant pertuzumab, trastuzumab and chemotherapy … O Ates, OB Oksuzoglu, BY Aktas, I Karadag, S Esen, S Karakaya, D Uncu, ... J. BUON 26, 1398-1404, 2021 | 3 | 2021 |
| The easy way of evaluating exocrine pancreatic insufficiency in type 2 diabetes: listen to the patients’ complaints and look in their eyes Z Aksoz, T Akkan, E Beyan, M Dagdeviren, A Mete Yildirim, I Karadag, ... Acta gastro-enterologica Belgica 83 (3), 407-412, 2020 | 3 | 2020 |
| Clinical outcomes and prognostic factors in HER-2 positive breast cancer with brain metastasis: A single-center experience. S Karakaya, İ Karadağ, AO Duran, OB Oksuzoglu, U Demirci Journal of Clinical Oncology 38 (15_suppl), e13015-e13015, 2020 | 3 | 2020 |
| Evaluatıon Of Sars-Cov-2 Infectıon In Cancer Patıents: Sıngle-Center Experıence From Turkey A Ilhan Güleşen, S Karakaya, İ Karadağ, S Ceken, B Oksuzoglu Acta Oncologica Turcica 53 (3), 441-447, 2020 | 3 | 2020 |
| The potential prognostic marker tyG index predicts time to brain metastasis at HER2 positive breast cancer I Karadag, S Karakaya, T Akkan, B Demir, EG Alkurt, M Dogan Cancer Management and Research, 311-317, 2023 | 2 | 2023 |
| Ideal lymph node number for ovarian malignancies İ Karadağ, S Karakaya Cureus 14 (1), 2022 | 2 | 2022 |
| Lorlatinib-Related Vision Loss: Two Cases of Non-Small Cell Lung Cancer with Blindness S KARAKAYA, ÖA YILDIRIM, Ş IŞIK, Ş YÜCEL, İ KARADAĞ | 1 | 2023 |
| CA-125/CEA RATIO AS A PROGNOSTIC FACTOR IN TYPE II ENDOMETRIAL CANCER: A SINGLE INSTITUTE EXPERIENCE İ KARADAĞ, S KARAKAYA, Ö ATEŞ, ÖBÇ ÖKSÜZOĞLU | 1 | 2022 |
| The invisible part of “ICEBERG”: Extraintestinal findings and celiac diseas S KARAKAYA, İ KARADAĞ, M Aslıhan, O BULUR, M UZMAN, E BEYAN Turkish Journal of Clinics and Laboratory 13 (1), 64-70, 2022 | 1 | 2022 |
